Tratamiento de la distonia focal con toxina botulinica / Treatment of focal dystonia with botulinic toxin
Rev. méd. Panamá
;
21(3): 121-131, Sept. 1996.
Artigo
em Espanhol
| LILACS
| ID: lil-409865
ABSTRACT
Dystonia is a neurologic disease characterized by involuntary repetitive muscular contractions which frequently causes torsion, spasmodic movements or abnormal postures. Pharmacologic and surgical treatment had been unsatisfactory in the majority of the cases. Intramuscular botulinic toxin application in focal dystonia disorders, achieve relief in approximately 90% of the cases by quimiodenervation. We included 35 patients with focal dystonia treated between November 1994 through June 1996: 14 facial hemispasm, nine blepharospasm, five cervical dystonia, two writer's cramps, one oromandibular dystonia and four patients with mixed focal dystonia. Improvement between 50-90% was observed in 32/34 (94%) of the patients; one case (2.8%) with therapeutic failure and one case (2.8%) never returned to quantify the response. Actually, botulinic toxin is the first choice treatment of focal dystonia and other diseases related to involuntary muscle spasm
Buscar no Google
Índice:
LILACS (Américas)
Assunto principal:
Toxinas Botulínicas
/
Distonia
Tipo de estudo:
Estudo observacional
Limite:
Adolescente
/
Adulto
/
Feminino
/
Humanos
/
Masculino
Idioma:
Espanhol
Revista:
Rev. méd. Panamá
Assunto da revista:
Medicina
Ano de publicação:
1996
Tipo de documento:
Artigo
País de afiliação:
Panamá
Similares
MEDLINE
...
LILACS
LIS